Patent · US Active

Vaccine

US7858098B2 · kind B2 · utility

3Cited by

9References

34Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Gary Dubin · Zürich, CH
Bruce Innis · King of Prussia, US
Moncef Slaoui · King of Prussia, US
Martine Anne Cecile Wettendorff · Sint-Genesius-Rode, BE

Key dates

Filing date	Dec 16, 2005
Grant date	Dec 28, 2010
Priority date	—
Expiry date	Oct 13, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/20034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.